ArticlePharmacoEconomics2014

The impact of structural uncertainty on cost-effectiveness models for adjuvant endocrine breast cancer treatments: the need for disease-specific model standardization and improved guidance.

Gerardus W J Frederix et al.PubMed ↗Publisher ↗

No numbers read from the abstract.